Pfizer Inc. (NYSE:PFE)

The profitability metrics exhibited considerable fluctuation throughout the observed period. Initial quarters demonstrated strong performance, followed by a period of decline, and a subsequent recovery towards the end of the timeframe. A notable divergence in trends is apparent between gross profitability and operating/net profitability, suggesting shifts in operational efficiency and expense management.

Gross Profit Margin

The gross profit margin generally increased from 60.35% in April 2022 to a peak of 74.33% in December 2025. A significant dip occurred between October 2022 and December 2023, falling from 65.53% to 58.10%, before recovering strongly. The most recent quarters show a consistent upward trend, indicating improved cost of goods sold management or pricing strategies.

Operating Profit Margin

The operating profit margin displayed a more volatile pattern. It rose from 26.12% to 34.83% through December 2022, then experienced a substantial decline, reaching a low of 2.15% in December 2023. A recovery began in early 2024, culminating in 22.76% by December 2025. This suggests increasing operating expenses or decreased revenue growth impacted profitability during the downturn.

Net Profit Margin

Mirroring the trend of the operating profit margin, the net profit margin also peaked in December 2022 at 31.27% before falling to 3.56% in December 2023. Negative values were recorded in March and June 2024 (-0.55% and -4.62% respectively), indicating net losses during those periods. The margin recovered to 12.42% by December 2025, though remaining below the initial levels.

Return on Equity (ROE)

ROE followed a similar trajectory to the profit margins, starting at 30.29% and declining to 2.38% by December 2023. A subsequent increase brought ROE to 8.99% in December 2025. The correlation with net income suggests that changes in equity also influenced this metric, alongside profitability.

Return on Assets (ROA)

ROA exhibited a parallel pattern, decreasing from 13.58% to 0.94% before recovering to 3.73% by the end of the period. The negative values in March and June 2024 (-0.14% and -1.20% respectively) align with the net loss periods. This indicates that the efficiency of asset utilization in generating profits was significantly impacted during the downturn and is improving with the recent recovery.

In summary, the observed period was characterized by a peak in profitability, followed by a significant decline, and a subsequent, though incomplete, recovery. The operating and net profit margins, along with ROE and ROA, experienced the most substantial fluctuations, indicating a sensitivity to changes in operating expenses, revenue, and potentially, equity structure. The recent upward trends in all metrics suggest a positive shift in performance, but levels remain below those observed in the initial quarters.

The gross profit margin exhibited considerable fluctuation throughout the observed period, beginning in April 2022 and extending through December 2025. An initial period of stability and increase was followed by a notable decline, then a recovery and subsequent stabilization at a higher level.

Initial Trend (Apr 2022 - Jul 2022)

The gross profit margin began at 60.35% in April 2022 and increased to 62.18% in July 2022. This suggests a positive trend in profitability during this timeframe, potentially driven by increased pricing power or improved cost management.

Peak and Subsequent Decline (Oct 2022 - Oct 2023)

The gross profit margin peaked at 65.53% in October 2022 and remained above 65% through December 2022. However, a consistent downward trend commenced in April 2023, falling from 68.61% to 60.97% by October 2023. This decline indicates increasing costs of goods sold relative to revenue, or potentially pricing pressures.

Recovery and Stabilization (Dec 2023 - Dec 2025)

Beginning in December 2023, the gross profit margin demonstrated a recovery, increasing from 58.10% to 74.33% by December 2025. This recovery suggests successful implementation of cost-cutting measures, improved operational efficiency, or a shift in product mix towards higher-margin offerings. The margin stabilized in the 72-74% range during the final three quarters, indicating a sustained improvement in profitability.

The most significant shift occurred between July 2023 and December 2023, representing a substantial turnaround in gross profitability. The final quarters of the period show a consistently high gross profit margin, suggesting a robust and sustainable improvement in the company’s underlying profitability.

Volatility

The overall period was characterized by volatility in the gross profit margin. The range extended from a low of 58.09% to a high of 74.33%, indicating sensitivity to external factors or internal operational changes.

Further investigation into the drivers behind the fluctuations, particularly the decline in the first half of 2023 and the subsequent recovery, would be beneficial for a more comprehensive understanding of the company’s financial performance.

The operating profit margin exhibited considerable fluctuation throughout the observed period. Initially, the metric demonstrated a positive trend, followed by a significant decline and subsequent recovery, though not to initial levels. A detailed examination reveals distinct phases in the company’s operational profitability.

Initial Growth & Peak (Apr 3, 2022 – Dec 31, 2022)

The operating profit margin began at 26.12% and steadily increased, peaking at 34.83% by the end of 2022. This period indicates improving operational efficiency and/or favorable pricing conditions. The increase suggests the company was effectively managing its costs relative to revenue generation.

Decline & Negative Territory (Apr 2, 2023 – Dec 31, 2023)

A marked downturn commenced in early 2023. The operating profit margin decreased from 34.44% to a negative 2.15% by the end of the year. This decline was particularly pronounced in the latter half of 2023, culminating in negative margins of -14.36% and -4.289%. This suggests a substantial increase in operating costs, a decrease in revenue, or a combination of both. The negative values indicate that operating expenses exceeded operating income during these quarters.

Recovery & Stabilization (Mar 31, 2024 – Dec 31, 2025)

Starting in the first quarter of 2024, the operating profit margin began to recover. It moved from -2.08% to 22.76% by the end of 2025. While the margin did not consistently return to the levels seen in 2022, it demonstrated a clear upward trajectory. Fluctuations were observed within this recovery phase, with margins reaching 9.56% in Q3 2024, then 19.51% in Q4 2024, and stabilizing between 19.29% and 23.23% through the first three quarters of 2025 before ending at 22.76%. This suggests successful cost control measures and/or revenue growth initiatives were implemented, though ongoing volatility remains.

Overall, the operating profit margin experienced a volatile period, transitioning from growth to significant decline and then to a recovery phase. The substantial negative margins in late 2023 warrant further investigation to understand the underlying drivers. The subsequent recovery indicates corrective actions were taken, but continued monitoring is necessary to assess the sustainability of the improved performance.

The net profit margin exhibited considerable fluctuation throughout the observed period. Initially, the metric demonstrated a strong performance, followed by a period of significant decline and eventual recovery, albeit with continued volatility.

Initial Strong Performance (Apr 3, 2022 – Dec 31, 2022)

From April 3, 2022, to December 31, 2022, the net profit margin consistently remained above 27%, peaking at 31.27% in the December 31, 2022, quarter. This indicates a robust ability to translate revenue into profit during this timeframe. A slight upward trend is observable within this period.

Decline and Negative Values (Apr 2, 2023 – Dec 31, 2023)

Beginning in April 2023, a marked decline in the net profit margin is evident. The metric decreased from 31.19% to a negative value of -3.56% by the end of 2023. The October 1, 2023, quarter saw a substantial drop to 15.13%, followed by further deterioration in the subsequent quarter. This suggests increasing costs or decreasing revenues, or a combination of both, impacting profitability.

Recovery and Volatility (Mar 31, 2024 – Dec 31, 2025)

The net profit margin began to recover in the first quarter of 2024, reaching 7.04% on March 31, 2024. However, this recovery was short-lived, with a significant drop to -4.62% in the June 30, 2024, quarter. Subsequent quarters showed improvement, peaking at 16.84% on June 29, 2025, but concluding the period with a decline to 12.42% on December 31, 2025. This indicates ongoing instability in profitability, despite overall positive figures in several quarters.

Overall Trend

While the net profit margin demonstrated a capacity to reach above 30%, the overall trend is characterized by significant volatility. The period from April 2023 through December 2024 was particularly challenging, with the metric experiencing negative values. The final quarters suggest a potential stabilization, but continued fluctuations remain a concern.

The Return on Equity (ROE) exhibited considerable fluctuation over the analyzed period, spanning from April 2022 to December 2025. Initially, the ROE demonstrated a strong performance, followed by a period of decline and eventual stabilization with some renewed growth.

Initial Strong Performance (Apr 2022 – Oct 2022)

The ROE began at 30.29% in April 2022 and peaked at 33.61% in July 2022, before slightly decreasing to 32.14% in October 2022. This period indicates a consistently high level of profitability relative to shareholder equity.

Decline and Negative Values (Dec 2022 – Mar 2024)

A noticeable downward trend commenced in December 2022, with the ROE falling to 32.79%. This decline accelerated through the subsequent quarters, culminating in negative ROE values of -0.33% in March 2024. The negative value in March 2024 suggests that the company experienced a loss relative to shareholder equity during that period.

Recovery and Stabilization (Apr 2024 – Dec 2025)

Following the negative ROE in March 2024, a recovery began, with the ROE reaching 9.11% by December 2024. This upward momentum continued into 2025, peaking at 12.12% in June 2025, before decreasing to 8.99% in December 2025. This suggests a return to profitability, although with some volatility.

The fluctuations in ROE appear to correlate with changes in net income attributable to Pfizer Inc. common shareholders. The significant decline in ROE during the latter part of 2022 and early 2023 coincided with a decrease in net income, and the negative ROE values directly reflect net losses. The subsequent recovery in ROE aligns with the return to positive net income in later periods. Total Pfizer Inc. shareholders’ equity generally increased over the period, but this increase did not consistently offset the impact of net income fluctuations on ROE.

Overall Trend

The overall trend indicates a period of strong profitability followed by a substantial decline and a subsequent recovery. While the ROE demonstrated improvement in the later quarters, it did not consistently return to the levels observed in the initial period of analysis.

The Return on Assets (ROA) exhibited a generally positive trajectory through the first three quarters of 2022, followed by significant fluctuations and a subsequent decline before showing signs of recovery. A detailed examination of the quarterly figures reveals distinct phases in the company’s asset utilization efficiency.

Initial Growth (Apr 3, 2022 – Oct 2, 2022)

The ROA increased consistently from 13.58% in April 2022 to a peak of 15.32% in October 2022. This indicates improving profitability relative to the asset base during this period. Net income attributable to Pfizer Inc. common shareholders also showed growth during this timeframe, contributing to the ROA increase.

Stabilization and Initial Decline (Dec 31, 2022 – Oct 1, 2023)

Following the peak, the ROA experienced a sharp decline, falling from 15.91% in December 2022 to 4.87% in October 2023. This coincided with a decrease in net income, culminating in a net loss in the third quarter of 2023. Total assets increased during this period, potentially exacerbating the decline in ROA as earnings did not keep pace with the growing asset base.

Recovery and Volatility (Dec 31, 2023 – Sep 28, 2025)

The ROA showed a partial recovery in the final quarter of 2023, reaching 3.76%. This trend continued into 2024, with ROA reaching 5.22% in June 2024. However, the ROA experienced volatility, decreasing to 4.71% in September 2025, before ending the period at 3.73% in December 2025. Net income fluctuations were a key driver of these changes. The return to positive net income in the first three quarters of 2024 contributed to the ROA improvement, while a net loss in the final quarter of 2025 negatively impacted the ratio.

Asset Base Considerations

Total assets generally increased throughout the observed period, peaking at 226,501 US$ in millions in December 2023, before decreasing slightly. The relationship between asset growth and net income is crucial to understanding the ROA trends. Periods of asset growth without corresponding income growth resulted in lower ROA values.

In summary, the ROA demonstrates a pattern of initial growth, followed by a substantial decline, and a subsequent, albeit volatile, recovery. The fluctuations in net income and the increasing asset base are the primary factors influencing these observed trends.